| Literature DB >> 26793273 |
Jan Kolek1, Karel Sedlar2, Ivo Provaznik2, Petra Patakova1.
Abstract
BACKGROUND: Butanol is currently one of the most discussed biofuels. Its use provides many benefits in comparison to bio-ethanol, but the price of its fermentative production is still high. Genetic improvements could help solve many problems associated with butanol production during ABE fermentation, such as its toxicity, low concentration achievable in the cultivation medium, the need for a relatively expensive substrate, and many more. Clostridium pasteurianum NRRL B-598 is non-type strain producing butanol, acetone, and a negligible amount of ethanol. Its main benefits are high oxygen tolerance, utilization of a wide range of carbon and nitrogen sources, and the availability of its whole genome sequence. However, there is no established method for the transfer of foreign DNA into this strain; this is the next step necessary for progress in its use for butanol production.Entities:
Keywords: Butanol; Clostridium; Conjugation; Dam; Dcm; Electroporation; Methylation; Sonoporation; Transformation
Year: 2016 PMID: 26793273 PMCID: PMC4719659 DOI: 10.1186/s13068-016-0436-y
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Methylated motif detected for C. pasteurianum NRRL B-598
| R-M system type | Motifs (±strand) | No. in genome | No. detected (±strand) | % detected (±strand) | Locus tag | Nomenclature |
|---|---|---|---|---|---|---|
| I | GRNTAYNNNNNNNRTTC/GAAYNNNNNNNRTANYC | 406 | 385/380 | 94.83/93.60 | X276_10630 | M.Cpa598I |
| I | CTAGNNNNNNRTC/GAYNNNNNNCTAG | 606 | 573/560 | 94.55/92.41 | X276_12360 | M.Cpa598II |
R-M systems in C. pasteurianum NRRL B-598 genome
| Type | Name | Genea | Meth. type | Recognition | Locus (X276_) | Most similar (% identity) |
|---|---|---|---|---|---|---|
| I | Cpa598IP | R | m6A | GAAYNNNNNNNRTANYC | 10620 | CspMORF4102P (95 %) |
| M.Cpa598I | M | 10630 | M.CbeG117ORFCP (97 %) | |||
| S.Cpa598I | S | 10635 | S.CspMORF4102P (49 %) | |||
| I | Cpa598IIP | R | m6A | GAYNNNNNNCTAG | 12355 | Csc25775ORFJP (90 %) |
| M.Cpa598II | M | 12360 | M.Csc25775ORFJP (96 %) | |||
| S.Cpa598II | S | 12365 | S.Bme201ORFGP (56 %) | |||
| II | M1.Cpa598ORF20205 | M | m5C | – | – | M1.CboKAPB3ORF12160P (87 %) |
| M2.Cpa598ORF20205 | M | 01545 | M2.CboKAPB3ORF12160P (84 %) | |||
| R1.Cpa598ORF20205 | R | – | R2.Cce743ORF4007P (46 %) | |||
| R2.Cpa598ORF20205 | R | 01555 | R1.Bce3081ORF2217P (31 %) | |||
| II | M.Cpa598ORF2410P | M | m6A | GATCb | 20735 | M.Cbe59BORF1284P (100 %) |
| IV | Cpa598ORF12465P | R | – | – | 12465 | Cdi15410ORFAP (93 %) |
a R restriction endonuclease, M restriction endonuclease coupled methylation protein, S R-M specific protein
b Predicted recognition site
Fig. 1Antibiotic resistance genes in C. pasteurianum NRRL B-598 genome. Overall resistance in the center, resistance classes in the middle, and individual resistance genes (and their NCBI accession numbers) on the outer ring
Fig. 2Testing the presence of potential restriction barriers. Cultivation of pMTL83253 (a) and pMTL82254 (b) with crude protoplast extract (PE) and whole cell lysate (WL) prepared from C. pasteurianum NRRL B-598 at 37 °C. Positive control (c): cultivation of pMTL83253 with PE prepared from C. pasteurianum DSM 525 by the same method
Fig. 3Confirmation of pMTL83253 presence in C. pasteurianum NRRL B-598 erythromycin-resistant transformants. a pMTL83253 isolated from E. coli JM110 (a1) and C. pasteurianum NRRL B-598 transformants (a2). b pMTL83253 isolated from E. coli JM110 (b2) and C. pasteurianum NRRL B-598 transformants (b3) cleaved by PstI (resulting fragments 370 bp and 4413 bp) compared to the GeneRuler 1 kb DNA ladder - Thermo Scientific (b1)
Fig. 4Optimization of electrotransformation conditions. Influence of various voltages and cell growth state presented by OD600 (used conditions: 0.2 cm gap electroporation cuvette, time constant 11 ms) on transformation efficiency (a); influence of different time constants (conditions used: 0.2 cm gap electroporation cuvette, voltage 1 000 V) on transformation efficiency (b); influence of square-wave pulse delivery (c)
Influence of DNA methylation stage to the electrotransformation efficiency
| DNA amount [μg]/ | CFU (average count)a | Efficiency (CFU per μg DNA) |
|---|---|---|
| 2 μg/DH5α ( | 3 | 1.5 |
| 2 μg/GM33 ( | 27 | 13.5 |
| 2 μg/BL21 ( | 28 | 14 |
| 2 μg/JM110 ( | 236 | 118 |
a2 μg of DNA was used for transformation
Summary of pMTL83353 containing CFU yielded by conjugation, sonoporation, and combined sono/electroporation approaches
| Method | CFU (average count) | Efficiency (CFU per μg DNA) |
|---|---|---|
| Conjugation ( | ||
| 6 h of conjugation | 12 | |
| 24 h of conjugation | 37 | |
| Sonoporation | ||
| 10 % PEG 8000 buffer, 20 s pulse | 225a | 112.5 |
| 30 % PEG 8000 buffer, 20 s pulse | 321a | 160.5 |
| Sono/electroporation | ||
| 30 % PEG 8000 buffer, 20 s ultrasound pulse, 5 ms square-wave pulse 5 ms (1250 V) | 265b | 530 |
a2 μg of DNA was used for transformation
b0.5 μg of DNA was used for transformation
Fig. 5Optimization of sono/electroporation conditions. Influence of various voltages and exponential and square-wave pulse deliveries (a); influence of DNA amount on transformation efficiency (b)
Summary of bacterial strains and plasmid DNA used in this thesis
| Bacterial strains | Genotype | Source |
|---|---|---|
|
| ARL collection (NRRL) | |
|
| Coding type II restriction system CpaAI | DSMZ |
|
|
| DSMZ |
|
|
| DSMZ |
|
|
| CGSC |
|
|
| CGSC |
|
|
| DSMZ |
|
| ||
| RP4 (RK2) | Coding IncP-based conjugation function | DSMZ |
|
| ||
| pMTL83353 |
| [ |
| pMTL82251 |
| [ |
| pMTL83253 |
| [ |
| pMTL84251 |
| [ |
| pMTL85251 |
| [ |